Screening Libraries

What is a Bioactive Screening Library?

The libraries consist of a unique and diverse collection of over 120,000 small molecules with validated biological and pharmacological activities
Safety and effectiveness of the compounds has been demonstrated by preclinical and clinical research, and many of the compounds are FDA-approved.
The collections of unique small molecules, which include inhibitors, activators, antagonists, and agonists, are focused on over 200 targets that are part of
    more than 20 signaling pathways . These pathways include, among many others, apoptosis, and the PI3K/Akt/mTOR, and MAPK pathways.